Eleana Hatzidaki
Florina, ESYE13, Greece
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Bridging the gap in familial hypercholesterolaemia detection: the EPIRUS familial hypercholesterolaemia reverse cascade project as a model for paediatric and family-based screening.
Journal: Cardiology in the young
Published: June 16, 2026
Personalized dendritic cell vaccination in cancer therapy: An evidence-based research study.
Journal: Journal of cancer research and therapeutics
Published: May 06, 2023
A novel platform for the production of autologous human antibodies.
Journal: Anti-cancer drugs
Published: September 22, 2022
Cancer Comprehensive Analysis in Gastric Carcinoma: Benefits and New Perspectives.
Journal: Case reports in oncology
Published: September 13, 2021
A Novel Method for Colorectal Cancer Screening Based on Circulating Tumor Cells and Machine Learning.
Journal: Entropy (Basel, Switzerland)
Published: August 12, 2021
Increased breast cancer cell sensitivity to cisplatin using a novel small molecule inhibitor.
Journal: Journal of cancer research and therapeutics
Published: December 21, 2020
Novel antibody against TMX2 and its effects on breast cancer cells.
Journal: International journal of biochemistry and molecular biology
Published: September 24, 2019
Novel small molecule decreases cell proliferation, migration, clone formation, and gene expression through ERK inhibition in MCF-7 and MDA-MB-231 breast cancer cell lines.
Journal: Anti-cancer drugs
Published: February 12, 2019
The use of serum extracellular vesicles for novel small molecule inhibitor cell delivery.
Journal: Anti-cancer drugs
Published: November 30, 2018
MGMT repletion after treatment of glioblastoma cells with temozolomide and O6-benzylguanine implicates NFκB and mutant p53.
Journal: Neurological research
Published: April 09, 2013
Bortezomib overcomes MGMT-related resistance of glioblastoma cell lines to temozolomide in a schedule-dependent manner.
Journal: Investigational new drugs
Published: February 06, 2013
Bortezomib downregulates MGMT expression in T98G glioblastoma cells.
Journal: Cellular and molecular neurobiology
Published: November 04, 2012
Last Updated: 09/26/2026